Table 1 Clinicopathological characteristics of 458 patients with single SHCC
From: Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma
Clinicopathological features | Valuea |
|---|---|
Age(yr), mean (median) | 52.65 (52) |
Sex | |
Male | 384 (84.0%) |
Female | 74 (16.0%) |
Pre-operation AFP value ≥200 ug/mla | 147 (33.0%) |
Post-operation AFP value ≥20 ug/mlb | 178 (63.6%) |
Virus infectionc | |
No virus | 30 (6.6%) |
HBV | 421 (92.0%) |
HCV | 4 (1.0%) |
HBV&HCV | 1 (0.2%) |
HBV&HEV | 1 (0.2%) |
Cirrhosis | |
Y | 411 (89.7%) |
N | 47 (10.3%) |
Capsulary formationd | |
Y | 249 (55.5%) |
N | 200 (44.5%) |
Tumor bordere | |
Clearly | 434 (97.3%) |
Vaguely | 12 (2.7%) |
Tumor histological differentiation | |
Well differentiated | 14 (3.1%) |
Moderately differentiated | 345 (75.3%) |
Poorly differentiated | 99 (21.6%) |
Tumor microscopic manifestation | |
MVI | |
Y | 83 (18.1%) |
N | 375 (81.9%) |
Tumor infiltrative lymphocytes | |
≥50/HPF | 84 (18.3%) |
<50/HPF | 374 (81.7%) |
Clear cell subtype | |
Y | 23 (5.0%) |
N | 435 (95.0%) |
Tumor fatty change | |
Y | 15 (3.3%) |
N | 443 (96.7%) |
Large cell dyplastic change | |
Y | 36 (7.9%) |
N | 422 (92.1%) |
Peritumor liver fatty change | |
Y | 90 (19.7%) |
N | 368 (80.3%) |
PFS(mo),median(range) | 53.00 (4-75) |
OS(mo),median(range) | 54.00 (21-75) |